Skip to main content
Log in

Salutary effect of tedisamil on post-ischemic recovery rat heart: Involvement of sarcolemmal (Na,K)-ATPase

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The in vitro effect of tedisamil on the specific activity and kinetic parameters of the sarcolemmal (Na,K)-ATPase as well as its ex vivo effect on the (Na,K)-ATPase in the isolated, perfused rat hearts was determined. Five μmol/l of tedisamil was added 5 min before the onset of 30 min global normothermic ischemia followed by 10 min reperfusion. At the conditions of its maximal cardioprotective effect (heart rate reduction, improved postischemic recovery of left ventricular developed pressure), the hearts were immediately used for isolation of sarcolemmal vesicles. In vitro, 1–100 μmol/l of tedisamil produced a concentration-dependent stimulatory effect on (Na,K)-ATPase activity, with a peak seen at 20 μmol/l (p < 0.01), while Mg-dependent ATPase was almost unchanged. Kinetic analysis revealed a significant increase in the affinity of the Na-binding sites on ATPase molecule at 20 μmol/l of tedisamil. These biochemical findings were confirmed by cytochemistry. Moreover, ex vivo experiments revealed that tedisamil rendered the sarcolemmal (Na,K)-ATPase activity to be a more resistant to detrimental effects of ischemia. In conclusion, the cardioprotective action of tedisamil was accompanied with a better preservation of the specific activity of (Na,K)-ATPase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shou N, Antel J, Bruckner R, Messinger J, Franke R, Gruska A: Synthesis, pharmacological characterization and quantitative structureactivity relationship analysis of 3,7,9,9-tetraalkylbispidine: Derivatives with specific bradycardiac activity. J Med Chem 41: 318–331, 1998

    Google Scholar 

  2. Bray K, Oast U: Differential inhibition by tedisamil (KC 8857) and glibenclamide of the responses to cromakalim and minoxidil sulphate in rat isolated aorta. Naunym Schmied Arch Pharmacol 345: 24–31, 1992

    Google Scholar 

  3. Wettwer E, Himmel HM, Amos CJ, Li Q, Metzger F, Ravens N: Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes. Br J Pharmacol 125: 659–666, 1998

    Google Scholar 

  4. Dzimiri NN, Fricke U, Klan W: Influence of derivation on the lipophilicity and inhibitory action of cardiac glycosides on Na,K-ATPase. Br J Pharmacol 91: 31–38, 1987

    Google Scholar 

  5. Džurba A, Vrbjar N, Breier A, Ziegelhöffer A: The membrane effect of Benfluron: Modulation of the heart sarcolemmal (Na,K)-ATPase and Mg-ATPase activities. Gen Physiol Biophys 15: 71–75, 1996

    Google Scholar 

  6. Vrbjar N, Džurba A, Ziegelhöffer A: Enzyme kinetics and the activation energy of (Na,K)-ATPase in ischaemic hearts: Influence of the duration of ischaemia. Gen Physiol Biophys 13: 405–411, 1994

    Google Scholar 

  7. Tsuchiya K, Horie M, Haruna T, Ai T, Mishimoto T, Fujiwara H, Sasayama S: Functional communication between cardiac ATP-sensitive potassium channel and Na/K-ATPase.J Cardiovasc Electrophysiol 9: 415–422, 1998

    Google Scholar 

  8. RavingerováT, Wu S, Pancza D, Džurba A, Ziegelhöffer A, Parrat J: Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: Relevance to ischemic preconditioning. Exp Clin Cardiol 2: 19–24, 1997

    Google Scholar 

  9. Pitts B: Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. J Biol Chem 254: 6233–6235, 1979

    Google Scholar 

  10. Taussky H, Schorr E: A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202: 675–685, 1953

    Google Scholar 

  11. Lowry O, Rosebrough N, Farr A, Randall R: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951

    Google Scholar 

  12. Slezák J, OkruhlicováL, TribulováN, Schulze W, Dhalla NS: Renaissance of cytochemical localization of membrane ATPases in the myocardium. Mol Cell Biochem 147: 169–172, 1995

    Google Scholar 

  13. Shinmura K, Tani M, Hasegawa H, Nakamura Y: Effect of E-4031, a class III antiarrhythmic drug on ischemia and reperfusion-induced arrhythmias in isolated rat hearts. Jpn Heart J 39: 183–197, 1998

    Google Scholar 

  14. Mitrovic V, Oehm E, Strasser R, Schlepper M, Pitschner H: Hemodynamic, antiischemic, and neurohumoral effects of the new potassium channel blocking agent tedisamil in patients with coronary artery disease. Ztsch Kardiol 85: 961–972, 1996

    Google Scholar 

  15. Kramer J, Owens K, Weglicki W: Cardiac sarcolemmal (Na,K)-ATPase: Combined effect of propranolol and arachidonyl CoA. Am J Physiol 244: 4738–4742, 1983

    Google Scholar 

  16. DÓurba A, Ziegelhöffer A, SchmidtováL, Breier A, Vrbjar N, Okoli anýJ: Exaprolol as modulator of heart sarcolemmal (Na, K)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzyme. Gen Physiol Biophys 4: 257–264, 1985

    Google Scholar 

  17. Džurba A, Bárta E, Styk J, Okoli á ny J, Ziegelhöffer A: The influence of exaprolol upon the ischemic rat heart and its interaction with sarcolemmal (Na,K)-ATPase. Physiol Bohemoslov 38: 29–39, 1989

    Google Scholar 

  18. Džurba A, Vrbjar N, Ziegelhöffer A: Nitrendipine modulates the sodium binding site of cardiac (Na,K)-ATPase. Life Sci 52: 1175–1179, 1993

    Google Scholar 

  19. Džurba A, Ziegelhöffer A, Vrbjar N, Styk J, Slezák J: Estradiol modulates the sodium pump on the heart sarcolemma. Mol Cell Biochem 176: 113–118, 1997

    Google Scholar 

  20. Berger F, Borchard U, Hafner D, Putz I, Weis TM: Effect of 17 betaestradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn Schmied Arch Pharmacol 356: 788–796, 1998

    Google Scholar 

  21. Džurba A, Ziegelhöffer A, Breier A, Vrbjar A, Szekeres L: Increase activity of sarcolemmal (Na,K)-ATPase is involved in the late cardioprotective action of 7-oxo-prostacyclin. Cardioscience 2: 7–10, 1991

    Google Scholar 

  22. RavingerováT, Styk J, Tré gerováV, Pancza D, Slezák J, TribulováN, Ziegelhöffer A, Pissarek M, Szekeres L: Protective effect of 7-oxoprostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox. Basic Res Cardiol 86:245–253, 1991

    Google Scholar 

  23. Ziegelhöffer A, Ravingerova T, Styk J, ŠbokováJ, WaczulikováI, Breier A, Džurba A, Volkovova K, Čársky J, TureckýL: Mechanism that may be involved in calcium tolerance of the diabetic heart. Mol Cell Biochem 176: 191–1987, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Džurba, A., Ziegelhöffer, A., Okruhlicová, L. et al. Salutary effect of tedisamil on post-ischemic recovery rat heart: Involvement of sarcolemmal (Na,K)-ATPase. Mol Cell Biochem 215, 129–133 (2000). https://doi.org/10.1023/A:1026583523041

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026583523041

Navigation